U.S. Markets closed

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.65+0.05 (+1.92%)
At close: 4:00PM EDT

2.65 0.00 (0.00%)
After hours: 6:27PM EDT

People also watch
ALIMAVEOECYTAEGRINFI
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue17,35719,2635,217
Cost of Revenue12,3151,770-
Gross Profit5,04217,4935,217
Operating Expenses
Research Development21,40222,48824,520
Selling General and Administrative15,59714,20318,346
Non Recurring-756756
Others---
Total Operating Expenses---
Operating Income or Loss-31,957-19,954-37,649
Income from Continuing Operations
Total Other Income/Expenses Net9181,7206,935
Earnings Before Interest and Taxes-31,039-18,234-30,714
Interest Expense12,1525,4052,639
Income Before Tax-43,191-23,639-33,353
Income Tax Expense-34760-
Minority Interest---
Net Income From Continuing Ops-43,157-24,399-33,353
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-43,157-24,399-33,353
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-43,157-24,399-33,353